1932

Abstract

Allergic bronchopulmonary aspergillosis (ABPA) is a syndrome seen in patients with asthma and cystic fibrosis. It is characterized by chronic colonization of the airways with a ubiquitous fungus, . The clinical expression of ABPA results from the complex interaction of chronic colonization of the airways with , host factors allowing this colonization, and the host's genetically determined immune response. Clinically the syndrome is characterized by recurrent episodes of wheezing, mucus production, pulmonary infiltrates, and elevated levels of serum IgE. Many patients develop central bronchiectasis, and a subset will go on to end-stage fibrotic lung disease. It is thought that treatment will prevent this progression. The mainstay of therapy remains oral corticosteroids.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.med.50.1.303
1999-02-01
2024-04-15
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.med.50.1.303
Loading
/content/journals/10.1146/annurev.med.50.1.303
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error